Clinical Trial

Efficacy of Early Rhythm Control in AF With TR Patients

Study acronym: TRAF
Recruiting
View on ClinicalTrials.gov →
Summary
Atrial fibrillation is frequently accompanied by tricuspid regurgitation and may contribute to right atrial and tricuspid annular remodeling, leading to progression of tricuspid regurgitation and adverse clinical outcomes. However, whether early rhythm control improves prognosis in patients with atrial fibrillation and tricuspid regurgitation remains unclear. This study will compare early rhythm control with usual care in these patients, using a composite outcome of cardiac death, heart failure admission, stroke, and tricuspid valve surgery.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-19.
Trial Details
NCT Number NCT07607093
Lead Sponsor Samsung Medical Center
Conditions Atrial Fibrillation (AF), Tricuspid Regurgitation (TR)
Enrollment 5,800 participants
Start Date 2026-02-18
Primary Completion 2027-02-28 (estimated)
Study Completion 2027-02-28 (estimated)
Updated on ClinicalTrials.gov 2026-05-29